|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.402
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.354
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.304
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.256
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.233
|
|
|
|
regulation of glycogen catabolic process
|
GO:0005981 |
2 |
0.211
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.189
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.184
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.147
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.111
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.107
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.097
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.096
|
|
|
|
negative regulation of b cell differentiation
|
GO:0045578 |
4 |
0.093
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.087
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.082
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.082
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.081
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.079
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.078
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.072
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.069
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.066
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.065
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.065
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.064
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.063
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.062
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.061
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.061
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.060
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.060
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.060
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.059
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.058
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.058
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.056
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.056
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.055
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.054
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.054
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.053
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.053
|
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
12 |
0.051
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.050
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.050
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.049
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.049
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.046
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.046
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.043
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.042
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.042
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.042
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.040
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.039
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.039
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.039
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.038
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.037
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.037
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.037
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.037
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.037
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.037
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.037
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.037
|
|
|
|
negative regulation of apoptotic cell clearance
|
GO:2000426 |
1 |
0.036
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.036
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.035
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.035
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.035
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.035
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.035
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.035
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.034
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.034
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.033
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.033
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.033
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.032
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.032
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.032
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.032
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.032
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.032
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.032
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.031
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.031
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.031
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.031
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.030
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.030
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.030
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.030
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.029
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.029
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.029
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.029
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.029
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.029
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.029
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.029
|
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
17 |
0.029
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.029
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.029
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.029
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.029
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.028
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.028
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.028
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.028
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.028
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.028
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.028
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.028
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.028
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.028
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.027
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.027
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.027
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.027
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.027
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.027
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.027
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.027
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.026
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.026
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.026
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.026
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.025
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.025
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.025
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.025
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.025
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.025
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.024
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.024
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.024
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.024
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.024
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.024
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.024
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.024
|
|
|
|
negative regulation of mrna splicing via spliceosome
|
GO:0048025 |
12 |
0.024
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.024
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.024
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.023
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.023
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.023
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.023
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.023
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.023
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.022
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.022
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.022
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.022
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.022
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.022
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.022
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.022
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.022
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.022
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.021
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.021
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.021
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.021
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.021
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.021
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.021
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.021
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.021
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.021
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.021
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.021
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.021
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.021
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.021
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.020
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.020
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.020
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.020
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.020
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.020
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.020
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.020
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.020
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.020
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.020
|
|
|
|
positive regulation of glycogen catabolic process
|
GO:0045819 |
2 |
0.020
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.020
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.020
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.020
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.019
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.019
|
|
|
|
negative regulation of rna splicing
|
GO:0033119 |
12 |
0.019
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.019
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.019
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.019
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.019
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.019
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.018
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.018
|
|
|
|
negative regulation of mrna processing
|
GO:0050686 |
12 |
0.018
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.018
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.018
|
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.018
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.018
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.018
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.018
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.018
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.018
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.018
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.018
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.018
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.018
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.018
|
|
|
|
regulation of b cell differentiation
|
GO:0045577 |
23 |
0.017
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.017
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.017
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.017
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.017
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.017
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.017
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.017
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.017
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.017
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.017
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.017
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.017
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.017
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.017
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.017
|
|
|
|
negative regulation of b cell activation
|
GO:0050869 |
27 |
0.016
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.016
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.016
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.016
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.016
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.016
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.016
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.016
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.016
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.016
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.016
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.016
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.016
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.016
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.016
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.016
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.016
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.016
|
|
|
|
dna replication independent nucleosome assembly
|
GO:0006336 |
1 |
0.016
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.015
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.015
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.015
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.015
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.015
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.015
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.015
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.015
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.015
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.015
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.015
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.015
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.015
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.015
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.015
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.015
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.015
|
|
|
|
regulation of vacuole organization
|
GO:0044088 |
4 |
0.015
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.014
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.014
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.014
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.014
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.014
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.014
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.014
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.014
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.014
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.014
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.014
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.014
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
cellular polysaccharide catabolic process
|
GO:0044247 |
5 |
0.013
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.013
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.013
|
|
|
|
positive regulation of cellular carbohydrate metabolic process
|
GO:0010676 |
29 |
0.013
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.013
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.013
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.013
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.013
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.013
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.013
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.013
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.013
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.013
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.013
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.013
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.013
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.013
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.013
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.013
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.013
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.013
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.013
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.013
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.013
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.012
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.012
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.012
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.012
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.012
|
|
|
|
regulation of synapse structural plasticity
|
GO:0051823 |
4 |
0.012
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.012
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.012
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.012
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.012
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.012
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.012
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.012
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.012
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.012
|
|
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.012
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.012
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.012
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.012
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.012
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.012
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.012
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.012
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.012
|
|
|
|
sperm individualization
|
GO:0007291 |
1 |
0.012
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.012
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.011
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.011
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.011
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.011
|
|
|
|
positive regulation of translational initiation
|
GO:0045948 |
4 |
0.011
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.011
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.011
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.011
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.011
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.011
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.011
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.011
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.011
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.011
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.011
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.011
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.011
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.011
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.011
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.011
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.011
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.011
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.011
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.011
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.011
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.011
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.011
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.011
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.011
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.011
|
|
|
|
positive regulation of glucose metabolic process
|
GO:0010907 |
21 |
0.011
|
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.011
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.011
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.011
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.011
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.011
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.011
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.011
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.011
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.011
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.011
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.010
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.010
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.010
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.010
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.010
|
|
|
|
ribosomal small subunit biogenesis
|
GO:0042274 |
4 |
0.010
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.010
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.010
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.010
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.010
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.010
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.010
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.010
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.010
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.010
|
|
|
|
response to cold
|
GO:0009409 |
19 |
0.010
|
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.010
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.010
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.010
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.010
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.010
|
|
